Search Results - "Apfel, Stuart"
-
1
Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study
Published in Journal of sexual medicine (01-01-2020)“…Flibanserin is approved in the United States and Canada for the treatment of hypoactive sexual desire disorder in premenopausal women. The purpose of this…”
Get full text
Journal Article -
2
Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
Published in International review of neurobiology (2002)“…Since their discovery in the 1950s, neurotrophic factors have raised expectations that their clinical application to neurodegenerative diseases might provide…”
Get more information
Journal Article -
3
Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis
Published in Journal of women's health (Larchmont, N.Y. 2002) (01-11-2017)“…Flibanserin, a 5-HT agonist and 5-HT antagonist, is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in…”
Get more information
Journal Article -
4
Botulinum toxin for neuropathic pain?
Published in Neurology (28-04-2009)Get full text
Journal Article -
5
Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic Polyneuropathy: A Randomized Controlled Trial
Published in JAMA : the journal of the American Medical Association (01-11-2000)“…CONTEXT Nerve growth factor is a neurotrophic factor that promotes the survival of small fiber sensory neurons and sympathetic neurons in the peripheral…”
Get full text
Journal Article -
6
Neurotrophic factors in the therapy of diabetic neuropathy
Published in The American journal of medicine (30-08-1999)“…A large number of neurotrophic factors that exert effects on specific neuronal populations in the peripheral nervous system have been discovered. Some of these…”
Get more information
Journal Article -
7
Is the therapeutic application of neurotrophic factors dead?
Published in Annals of neurology (01-01-2002)Get full text
Journal Article -
8
Neurotrophic factor therapy--prospects and problems
Published in Clinical chemistry and laboratory medicine (01-04-2001)“…Over the past 15 years neurotrophic factors have generated considerable excitement for their potential as therapy for a wide variety of degenerative…”
Get more information
Journal Article -
9
Neurotrophic Factors and Pain
Published in The Clinical journal of pain (01-06-2000)“…Neurotrophic factors have been shown to play significant roles in the transmission of physiologic and pathologic pain. Nerve growth factor appears to be…”
Get full text
Journal Article -
10
Thalidomide neuropathy: too much or too long?
Published in Neurology (22-06-2004)Get full text
Journal Article -
11
Neurotrophic factors and diabetic peripheral neuropathy
Published in European neurology (01-01-1999)“…Recent evidence from animal models of diabetes and human diabetic subjects suggests that the reduced availability of neurotrophic factors may contribute to the…”
Get more information
Journal Article -
12
Nerve growth factor administration protects against experimental diabetic sensory neuropathy
Published in Brain research (14-01-1994)“…Small fiber sensory neuropathy is one of the most common complications of diabetes mellitus. Currently there is no adequate therapy to prevent this often…”
Get more information
Journal Article -
13
Nerve Growth Factor Regulates the Expression of Brain-Derived Neurotrophic Factor mRNA in the Peripheral Nervous System
Published in Molecular and cellular neuroscience (01-02-1996)“…Neurotrophins are profound regulators of neuronal survival in the developing peripheral nervous system and are synthesized by peripheral neurons themselves…”
Get full text
Journal Article -
14
Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study
Published in Journal of sexual medicine (14-11-2019)“…Abstract Introduction Flibanserin is approved in the United States and Canada for the treatment of hypoactive sexual desire disorder in premenopausal women…”
Get full text
Journal Article -
15
-
16
Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice
Published in Brain research (07-11-1997)“…Vincristine is a commonly used antitumor agent whose major dose-limiting side-effect is a mixed sensorimotor neuropathy. To assess whether insulin-like growth…”
Get full text
Journal Article -
17
Pooled safety analysis of high-specific-activity I-131 MIBG in iobenguane scan positive cancer patients
Published in Journal of clinical oncology (01-02-2019)“…Abstract only 388 Background: Iobenguane scan positive cancers include pheochromocytoma and paraganglioma (PPGL), neuroblastoma, and gastroenteropancreatic…”
Get full text
Journal Article -
18
Nerve growth factor prevents toxic neuropathy in mice
Published in Annals of neurology (01-01-1991)“…Taxol is a promising new antitumor drug with therapeutic use that is limited by a toxic sensory neuropathy. Taxol is also cytotoxic to dorsal root ganglion…”
Get more information
Journal Article -
19
Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Published in The Journal of nuclear medicine (1978) (01-05-2019)“…Patients with metastatic or unresectable (advanced) pheochromocytoma and paraganglioma (PPGL) have poor prognoses and few treatment options. This multicenter,…”
Get full text
Journal Article -
20
Efficacy and Safety of High-Specific-Activity 131 I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Published in Journal of Nuclear Medicine (01-05-2019)“…Patients with metastatic or unresectable (advanced) pheochromocytoma and paraganglioma (PPGL) have poor prognoses and few treatment options. This multicenter,…”
Get full text
Journal Article